Skip to content
healthcare.dev

doxorubicin hydrochloride, Liposomal

NDC 0338-9581, doxorubicin hydrochloride, injection, suspension, liposomal, from Baxter Healthcare Corporation.

Product NDC
0338-9581
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9581 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0338-9581-02003389581021 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02) / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b24afa8c-636b-4ace-99d5-51f445ad3123

Use it

Look up 0338-9581 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9581 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0338-9581. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.